secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001493152-24-009959
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX shareholders approve Serina merger, reverse stock split; close expected March 26
--------------------------------------------------------------------------------

- Stockholders approved issuance of >20% shares to Serina holders and change of control; 69M votes for, 6.6M against.
- Reverse stock split at 1-for-35.17 ratio effective March 14, 2024 at 10:00 AM ET; trading on split-adjusted basis from March 15.
- Merger with Serina expected to close March 26, 2024; combined company to be renamed Serina Therapeutics, ticker 'SER' on NYSE American from March 27.
- Also approved amended charter, post-merger warrants, 2024 equity plan, and governance provisions (classified board, no written consent).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224009959/0001493152-24-009959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224009959/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer